1-155236384-G-A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PP2PP3PP5_Very_Strong
The NM_000157.4(GBA1):c.1085C>T(p.Thr362Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000103 in 1,461,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000157.4 missense
Scores
Clinical Significance
Conservation
Publications
- Parkinson diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Gaucher diseaseInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
- Gaucher disease perinatal lethalInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
- late-onset Parkinson diseaseInheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Gaucher disease type IInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- Gaucher disease type IIInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- Gaucher disease type IIIInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
- Gaucher disease-ophthalmoplegia-cardiovascular calcification syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GBA1 | NM_000157.4 | c.1085C>T | p.Thr362Ile | missense_variant | Exon 8 of 11 | ENST00000368373.8 | NP_000148.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GBA1 | ENST00000368373.8 | c.1085C>T | p.Thr362Ile | missense_variant | Exon 8 of 11 | 1 | NM_000157.4 | ENSP00000357357.3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251480 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461878Hom.: 0 Cov.: 33 AF XY: 0.0000124 AC XY: 9AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Gaucher disease Pathogenic:3
Variant summary: GBA c.1085C>T (p.Thr362Ile) results in a non-conservative amino acid change located in the Glycosyl hydrolase family 30, TIM-barrel domain (IPR033453) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251480 control chromosomes (gnomAD). c.1085C>T has been reported in the literature in individuals affected with Gaucher Disease (He_1992, Erdos_2007, Lo_2011, Chan_2011, DAmore_2021). These data indicate that the variant is likely to be associated with disease. Functional studies report specific activity of this variant beta-glucosidases expressed in Sf9 cells was < 10% of normal activity (He_1992, Grace_1994). One ClinVar submitter (evaluation after 2014) cites the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
The p.Thr362Ile variant in GBA has been reported in at least 4 individuals with Gaucher disease (PMID: 17395504, 1301953, 25435509, 22713811) and has been identified in 0.003% (3/113762) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs76539814). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. In vitro functional studies provide some evidence that the p.Thr362Ile variant may slightly impact protein function (PMID: 1301953, 22713811). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in combination with reported pathogenic variants and in 4 individuals with Gaucher disease increases the likelihood that the p.Thr362Ile variant is pathogenic (VariationID: 4295, 4288; PMID: 17395504, 1301953, 25435509, 22713811). The phenotype of an individual heterozygous for this variant is highly specific for Gaucher disease based on beta-glucosidase assays showing <10% of normal enzyme activity, consistent with disease (PMID: 1301953). In summary, this variant meets criteria to be classified as pathogenic for Gaucher disease in an autosomal recessive manner based on multiple occurrences with pathogenic variants in affected individuals, low frequency in the general population, and in vitro functional studies. ACMG/AMP Criteria applied: PM3_strong, PM2, PS3_moderate, PP3, PP4 (Richards 2015). -
- -
Gaucher disease type I Pathogenic:1
- -
Gaucher disease type II;C0268251:Gaucher disease type III;C0752347:Lewy body dementia;C1842704:Gaucher disease perinatal lethal;C1856476:Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;C1961835:Gaucher disease type I;C3160718:Parkinson disease, late-onset Pathogenic:1
- -
not provided Pathogenic:1
- -
Gaucher disease type II Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at